NCT02336750View on ClinicalTrials.gov

Adding Mirtazapine to Dexamethasone and Aprepitant for Delayed Emesis

PHASE3CompletedINTERVENTIONAL
Enrollment

212

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Breast Cancer
Interventions
DRUG

Aprepitant

125mg D1, 80mg D2-3

DRUG

Mirtazapine

15mg D2-4

Trial Locations (1)

200032

Fudan University Cancer Hospital, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER

NCT02336750 - Adding Mirtazapine to Dexamethasone and Aprepitant for Delayed Emesis | Biotech Hunter | Biotech Hunter